A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06497556 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

338

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
KRAS G12C Lung Cancer

Interventions

DRUG: Divarasib
DRUG: Sotorasib
DRUG: Adagrasib

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]